4OKS
Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Compound 19 [[6-(3,5-diaminophenyl)-1-(2-methoxy-5-nitrobenzyl)-1H-indol-3-yl]acetic acid]
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X06SA |
Synchrotron site | SLS |
Beamline | X06SA |
Wavelength(s) | 0.9000 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 82.075, 103.343, 119.072 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 43.727 - 2.250 |
R-factor | 0.2067 |
Rwork | 0.204 |
R-free | 0.25790 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.009 |
RMSD bond angle | 1.236 |
Data reduction software | d*TREK (9.9.2L) |
Data scaling software | d*TREK (9.9.2L) |
Refinement software | PHENIX (1.8.4_1496) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 43.730 | 43.730 | 2.330 |
High resolution limit [Å] | 2.250 | 4.850 | 2.250 |
Rmerge | 0.080 | 0.040 | 0.610 |
Total number of observations | 31260 | 31584 | |
Number of reflections | 48716 | ||
<I/σ(I)> | 10.4 | 30.8 | 2.2 |
Completeness [%] | 100.0 | 99.8 | 100 |
Redundancy | 6.24 | 5.93 | 6.58 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 |